Filing Details
- Accession Number:
- 0001640334-20-002100
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-08-13 18:35:11
- Reporting Period:
- 2020-08-07
- Accepted Time:
- 2020-08-13 18:35:11
- Original Submission Date:
- 2020-08-11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1516551 | Emerald Bioscience Inc. | EMBI | Pharmaceutical Preparations (2834) | 450692882 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1728413 | Emerald Health Sciences Inc. | Office 8262 The Landing, 200-375 Water St. Vancouver A1 V6B 0M9 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-08-07 | 2,566,666 | $0.10 | 123,923,501 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The original Form 4, filed on August 11, 2020, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on August 7, 2020, as a total of 3,000,000 shares sold when in fact 2,566,6660 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects an addition in the number of shares reported as beneficially owned by the reporting person by 433,334 shares.
Billionaire Hedge Funds
